Transparency

Promoting transparent relations or interactions between companies and Healthcare Professionals / Organisations to relevant stakeholders assists informed decision-making and helps to prevent unethical and illegal behaviour.

We are committed to sharing details of our relationships with patient organisations, healthcare professionals and appropriate administrative staff; as well as details of all donations and grants provided to institutions, organisations or associations that are comprised of healthcare professionals and/or that provide healthcare or conduct research. Support for healthcare professionals and healthcare organisations will be published periodically on this website as per the Medicines for Europe Code of Conduct1.

 

hameln Transfer of Value 2018

hameln Transfers of Value 2019

2020: hameln pharma ltd made no transfers of values to HCPs for fees for service and consultancy or to healthcare or patient organisations in 2020.

2021: hameln pharma ltd made no transfers of values to HCPs for fees for service and consultancy or to healthcare or patient organisations in 2021.

2022: hameln pharma ltd made no transfers of values to HCPs for fees for service and consultancy or to healthcare or patient organisations in 2022.

 

1 http://www.medicinesforeurope.com